Mackram F. Eleid
Mayo Clinic
Internal medicineSurgeryCardiologyHemodynamicsMitral valve replacementAortic valve replacementMitral valveHeart failureStenosisValve replacementRegurgitation (circulation)Aortic valveMitraClipPercutaneousMitral regurgitationIn patientParavalvular leakTranscatheter aorticMedicineEjection fraction
Publications 292
#1Colleen E. Lane (Mayo Clinic)H-Index: 2
#2Jeremy J. Thaden (Mayo Clinic)H-Index: 11
Last. Mackram F. Eleid (Mayo Clinic)H-Index: 33
view all 3 authors...
2 CitationsSource
#1Khawaja M Talha (Mayo Clinic)H-Index: 2
#2Jack McHugh (Mayo Clinic)
Last. Larry M. Baddour (Mayo Clinic)H-Index: 90
view all 0 authors...
ABSTRACT null null Objective null To evaluate incidence and risk factors of bloodstream infections (BSI) in patients with transcatheter aortic valve replacement (TAVR). null null null Methods null We conducted a population-based study in southeastern Minnesota using the expanded Rochester Epidemiology Project (e-REP) for all adult (≥18 years) patients who underwent TAVR from January 1, 2010 to December 31, 2018. null null null Results null The incidence of BSI following TAVR was 1,300 episodes/1...
#1Li Tan YangH-Index: 11
#1Li-Tan Yang (NTU: National Taiwan University)H-Index: 1
Last. Hector I. Michelena (Mayo Clinic)H-Index: 47
view all 9 authors...
Objective To comprehensively explore contemporary differences between bicuspid aortic valve (BAV) and tricuspid aortic valve (TAV) patients with chronic haemodynamically significant aortic regurgitation (AR). Methods Consecutive patients with chronic ≥moderate-severe AR from a tertiary referral centre (2006–2017) were included. All-cause mortality, surgical indications and aortic valve surgery (AVS) were analysed. Results Of 798 patients (296 BAV-AR, age 46±14 years; 502 TAV-AR, age 67±14 years,...
#2Darrell B. NewmanH-Index: 5
Last. Hartzell V. Schaff (Mayo Clinic)H-Index: 131
view all 5 authors...
#1Bassim El-Sabawi (Mayo Clinic)H-Index: 6
#2Mayra Guerrero (Mayo Clinic)H-Index: 24
Last. Charanjit S. Rihal (Mayo Clinic)H-Index: 96
view all 6 authors...
OBJECTIVES To determine the incidence, characteristics, and outcomes of patients with hemolysis after transcatheter mitral valve replacement (TMVR). BACKGROUND Hemolysis is an increasingly recognized complication of TMVR. Clinical outcomes and optimal management for patients with hemolysis after TMVR are unclear. METHODS Patients that underwent mitral valve-in-valve (MViV), valve-in-ring (MViR), and valve-in-mitral annular calcification (ViMAC) at a single center were retrospectively assessed. R...
#1Madeline K. Mahowald (Mayo Clinic)H-Index: 3
#2Michel T. Corban (Mayo Clinic)H-Index: 12
Last. Rick A. Nishimura (Mayo Clinic)H-Index: 128
view all 4 authors...
#1Marvin H. Eng (HFHS: Henry Ford Health System)H-Index: 18
#2Amr E. Abbas (Beaumont Health)H-Index: 16
Last. William W. O'Neill (HFHS: Henry Ford Health System)H-Index: 31
view all 7 authors...
OBJECTIVE/BACKGROUND Small balloon expandable valves have higher echocardiographic transvalvular gradients and rates of prosthesis-patient mismatch (PPM) compared to larger valves. However, the impact of these echocardiographic findings on clinical outcomes is unknown. We sought to determine the clinical outcomes of 20 mm SAPIEN 3 (S3 BEV) compared to larger S3 BEV in relation to echocardiographic hemodynamics. METHODS Using the STS/ACC transcatheter valve registry, we performed a propensity-mat...